12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers Artelo Biosciences (NASDAQ:ARTL) shares rose 44.2% to $3.39 during Wednesday’s after-market session. Artelo Biosciences’s trading volume hit…
Cannabis Stock Gainers And Losers From August 24, 2023
GAINERS: EVIO (OTC:EVIO) shares closed up 9900.00% at $0.0001 Red White & Bloom Brands (OTC:RWBYF) shares closed up…
Marijuana Stock Movers For August 15, 2023
GAINERS: Red White & Bloom Brands (OTC:RWBYF) shares closed up 4900.00% at $0.01 GrowLife (OTC:PHOT) shares closed up…
Cannabis Stock Movers For July 24, 2023
GAINERS: Chalice Brands (OTC:CHALF) shares closed up 900.00% at $0.0001 Maple Leaf Green World (OTC:MGWFF) shares closed up…
Artelo Unvails New Data On ART26.12 Demonstrating Positive Effects In Multiple Models Of Neuropathic Pain
Professor Saoirse O’Sullivan, vice president of translational sciences at Artelo Biosciences, Inc.
Artelo Biosciences Announces New Data On ART26.12 Demonstrating Effects In Multiple Models Of Neuropathic Pain At The 33rd Annual International Cannabinoid Research Society Symposium
ART26.12, a Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor, Shows Favorable Results in Studies for Chemotherapy-Induced Neuropathy and Diabetic Neuropathy
ART26.12 targeting global neuropathic pain
Artelo Biosciences Presents Groundbreaking Research At Annual CBD Symposium In Canada
Artelo Biosciences, Inc.
Artelo Biosciences Reports Superior Preclinical Pharmaceutical Properties And Efficacy Of ART12.11 Compared To Cannabidiol At The 33rd Annual International Cannabinoid Research Society Symposium
ART12.11, a novel and patented cocrystal of CBD reverses the impact of chronic stress on outcomes of anxiety, depression, sociability and cognition
ART12.11 aims to address unmet needs within the global